At the news
? NEUTRALIMPACT 4/10 PRESS-RELEASE filed Feb 18, 2026 at 08:32 ET
Inspira Technologies announced the deployment of its FDA-cleared ART100 system at a top-ranked academic medical center in New York for a structured commercial evaluation. This expands its presence in the U.S. Tier-1 hospital market, supporting its commercial strategy, though no financial terms or outcomes were disclosed.
- Inspira Technologies deployed its ART100 system at a new U.S. academic medical center in New York.
- The institution is ranked among New York State’s top 10 hospitals in Newsweek’s World’s Best Hospitals 2025.
- The deployment is part of a structured commercial evaluation to assess clinical protocols and potential broader adoption.
- No financial figures, revenue impact, or contractual terms were disclosed.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access